|
OPC: Explanation for business result in Q3/2011
OPC Pharmaceutical JSC (HOSE: OPC) has explained business result in QIII/2011 as follows:
By: VND
|
|
QIII/2011 |
QIII/2010 |
Increase/Decrease |
Ratio |
|
Sales |
97,740,490,177 |
81,967,150,794 |
15,773,339,383 |
19% |
|
Profit after tax |
11,910,622,600 |
17,010,810,362 |
(5,100,187,762) |
-30% |
Profit after tax in QIII/2011 decreased 30%, or VND5,100,187,762, due to the increase in financial expense, including: The establishment of securities investment provision of VND2,168,000,000 and the bank interest expense of VND1,756,964,458.
HOSE
|
